Impacts of statin and metformin on neuropathy in patients with type 2 diabetes mellitus: Korean Health Insurance data
Hong Ki Min, Se Hee Kim, Jong Han Choi, Department of Internal Medicine, Konkuk University Medical Center, Seoul KS013, South Korea
Kyomin Choi, Department of Neurology, Konkuk University Medical Center, Seoul KS013, South Korea
Hae-Rim Kim, Sang-Heon Lee, Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine, Seoul KS013, South Korea
Author contributions: Min HK and Kim SH designed the research study; Min HK, Kim SH, Choi JH, Choi K and Kim HR performed the research; Min HK contributed analytic tools; Min HK analyzed the data and wrote the manuscript; all authors have read and approve the final manuscript.
Supported by the Konkuk University Medical Center Research Grant 2020.
Institutional review board statement: This study was approved by the Institutional Review Board of Konkuk University Medical Center (approval number: 2021-01-004).
Informed consent statement: The HIRA database is accessible to all researchers and holds anonymized patient information to protect the privacy of individuals. The HIRA database can be accessed by any researchers whose study protocols have been approved by an official review committee, and Informed consent of HIRA data is omitted. Therefore, written informed consent for enrollment was waived because the data were provided by HIRA.
Conflict-of-interest statement: The authors have no potential conflicts of interest to disclose.
Data sharing statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
STROBE statement: The authors have read the STROBE Statement—checklist of items, and the manuscript was prepared and revised according to the STROBE Statement—checklist of items.
: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Sang-Heon Lee, MD, Professor, Division of Rheumatology, Department of Internal Medicine, Konkuk University School of Medicine, 120 Neung-dong Ro, Gwangjin-gu, Seoul KS013, South Korea. email@example.com
Received: July 9, 2021
Peer-review started: July 9, 2021
First decision: August 8, 2021
Revised: August 9, 2021
Accepted: September 10, 2021
Article in press: September 10, 2021
Published online: November 26, 2021